Clinical Trial Update: Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates the effect of exendin (9-39) on glucose requirements to maintain euglycemia in congenital hyperinsulinism; study terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism

Drugs mentioned

• Exendin 9-39 (exendin-9-39)

Snippet

Sponsor: Diva De Leon | Conditions: Congenital Hyperinsulinism | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-05-14